Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2026-02-25 @ 10:05 PM
Study NCT ID:
NCT01886859
Status:
COMPLETED
Last Update Posted:
2022-09-26
First Post:
2013-06-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04-26
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-21
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-24
First Submit QC Date:
None
Study First Post Date:
2013-06-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-23
Last Update Post Date:
2022-09-26
Last Update Post Date Type:
ACTUAL